CYMGEN 30 mg


Capsule
scheduling status
S5
registration number
41/1.2/1029
What CYMGEN 30 mg contains
Each delayed-release capsule of CYMGEN 30 for oral administration contains enteric-coated pellets of duloxetine hydrochloride equivalent to 30 mg of duloxetine that are designed to prevent degradation of the medicine in the acidic environment of the stomach.
other ingredients
Carmoisine (E122), FD&C blue no. 2 aluminium lake (E132), gelatin, hypromellose, hypromellose acetate succinate, iron oxide yellow (E172), patent blue V (E131), propylene glycol, shellac(E904), sodium lauryl sulfate, sucrose, sugar spheres, talc, triethyl citrate, titanium dioxide (E171) Contains sugar: Sucrose 55,5 mg.
Therapeutic classification
A 1.2 Psychoanaleptics (antidepressants).
© 2026 SAHPRA. ALL RIGHTS RESERVED